It has been shown in basal cell carcinoma that mutations in the eRNA elements of ACTRT1 could impair enhancer activity and ACTRT1 expression, leading to aberrant activation of Hedgehog signaling and the contribution to tumor development [15]. The gene discussed is ACTRT1; the disease is basal cell carcinoma.